Medtech Pharma: China March 2019

The Trade Mission will comprise a program of site visits, business networking and opportunities for participating delegates to develop relationships with key players in China’s Medtech Pharma sector.

China is emerging as a significant market for Medtech and Pharma, with Pharmaceutical sales in China expected to rise from USD$108B in 2016, to USD$167B by 2020.

By 2022, it is expected that China’s annual growth rate, which currently averages 30 per cent of biomedical R&D will surpass the USA. The Greater Bay Area in particular presents significant opportunities for Medtech and Pharma companies. The Greater Bay area in China accommodates 68 million people with a total GDP output of US$1.4 trillion and been identified as an emerging commercial powerhouse to rival Silicon Valley.

Key dates

Mission dates: 28 March to 5 April 2019
Location: Shanghai and Greater Bay Area, China


For further information about this trade mission, send Libby O'Connor an email